2-(2,3-dicarboxycyclopropyl)glycine has been researched along with am 251 in 1 studies
Studies (2-(2,3-dicarboxycyclopropyl)glycine) | Trials (2-(2,3-dicarboxycyclopropyl)glycine) | Recent Studies (post-2010) (2-(2,3-dicarboxycyclopropyl)glycine) | Studies (am 251) | Trials (am 251) | Recent Studies (post-2010) (am 251) |
---|---|---|---|---|---|
166 | 0 | 27 | 948 | 1 | 507 |
Protein | Taxonomy | 2-(2,3-dicarboxycyclopropyl)glycine (IC50) | am 251 (IC50) |
---|---|---|---|
Cannabinoid receptor 1 | Homo sapiens (human) | 0.0892 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Konishi, S; Rusakov, D; Saitow, F; Satake, S | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and am 251
Article | Year |
---|---|
AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.
Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Benzoxazines; Calcium; Calcium Channel Blockers; Cerebellum; Chelating Agents; Colforsin; Cyclopropanes; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Wistar; Receptors, AMPA; Ryanodine; Synapses; Triazines; Triazoles | 2004 |